{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:23:35Z","timestamp":1780388615400,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s10067-014-2729-5","type":"journal-article","created":{"date-parts":[[2014,6,30]],"date-time":"2014-06-30T05:13:16Z","timestamp":1404105196000},"page":"1127-1134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Disease activity assessment in ankylosing spondylitis in a Chinese cohort: BASDAI or ASDAS?"],"prefix":"10.1007","volume":"33","author":[{"given":"Yuen Ling Elaine","family":"Au","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woon Sing Raymond","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo Yin","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Yin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chak Sing","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,1]]},"reference":[{"issue":"5","key":"2729_CR1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/rheumatology\/keh549","volume":"44","author":"KL Haywood","year":"2005","unstructured":"Haywood KL, Garratt AM, Dawes PT (2005) Patient-assessed health in ankylosing spondylitis: a structured review. Rheumatology (Oxford) 44(5):577\u2013586","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"2729_CR2","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/rheumatology\/38.9.878","volume":"38","author":"A Calin","year":"1999","unstructured":"Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M (1999) Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) 38(9):878\u2013882","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2729_CR3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","volume":"68","author":"C Lukas","year":"2009","unstructured":"Lukas C, Landewe R, Sieper J, Dougados M, Davis J, Braun J et al (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68(1):18\u201324","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"2729_CR4","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"D Heijde van der","year":"2009","unstructured":"van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J et al (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68(12):1811\u20131818","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2729_CR5","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s10067-007-0573-6","volume":"26","author":"JC Wei","year":"2007","unstructured":"Wei JC, Wong RH, Huang JH, Yu CT, Chou CT, Jan MS et al (2007) Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan. Clin Rheumatol 26(10):1685\u20131691","journal-title":"Clin Rheumatol"},{"issue":"3","key":"2729_CR6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1756-185X.2010.01537.x","volume":"13","author":"K Nas","year":"2010","unstructured":"Nas K, Yildirim K, Cevik R, Karatay S, Erdal A, Baysal O et al (2010) Discrimination ability of ASDAS estimating disease activity status in patients with ankylosing spondylitis. Int J Rheum Dis 13(3):240\u2013245","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"2729_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"P Machado","year":"2011","unstructured":"Machado P, Landewe R, Lie E, Kvien TK, Braun J, Baker D et al (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70(1):47\u201353","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2729_CR8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/rheumatology\/25.2.171","volume":"25","author":"NJ Sheehan","year":"1986","unstructured":"Sheehan NJ, Slavin BM, Donovan MP, Mount JN, Mathews JA (1986) Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis. Br J Rheumatol 25(2):171\u2013174","journal-title":"Br J Rheumatol"},{"issue":"4","key":"2729_CR9","first-page":"966","volume":"26","author":"J Ruof","year":"1999","unstructured":"Ruof J, Stucki G (1999) Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 26(4):966\u2013970","journal-title":"J Rheumatol"},{"issue":"6","key":"2729_CR10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/rheumatology\/keh595","volume":"44","author":"A Spoorenberg","year":"2005","unstructured":"Spoorenberg A, van Tubergen A, Landewe R, Dougados M, van der Linden S, Mielants H et al (2005) Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatology (Oxford) 44(6):789\u2013795","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"2729_CR11","first-page":"980","volume":"26","author":"A Spoorenberg","year":"1999","unstructured":"Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26(4):980\u2013984","journal-title":"J Rheumatol"},{"issue":"4","key":"2729_CR12","first-page":"971","volume":"26","author":"M Dougados","year":"1999","unstructured":"Dougados M, Gueguen A, Nakache JP, Velicitat P, Zeidler H, Veys E et al (1999) Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol 26(4):971\u2013974","journal-title":"J Rheumatol"},{"issue":"12","key":"2729_CR13","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1136\/ard.2010.129726","volume":"69","author":"L Eder","year":"2010","unstructured":"Eder L, Chandran V, Shen H, Cook RJ, Gladman DD (2010) Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis? Ann Rheum Dis 69(12):2160\u20132164","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2729_CR14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/ard.2003.016386","volume":"63","author":"M Rudwaleit","year":"2004","unstructured":"Rudwaleit M, Listing J, Brandt J, Braun J, Sieper J (2004) Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis 63(6):665\u2013670","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2729_CR15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2003.006916","volume":"63","author":"MA Stone","year":"2004","unstructured":"Stone MA, Payne U, Pacheco-Tena C, Inman RD (2004) Cytokine correlates of clinical response patterns to infliximab treatment of ankylosing spondylitis. Ann Rheum Dis 63(1):84\u201387","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"2729_CR16","first-page":"1751","volume":"32","author":"JC Davis Jr","year":"2005","unstructured":"Davis JC Jr, Van der Heijde DM, Dougados M, Braun J, Cush JJ, Clegg DO et al (2005) Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept. J Rheumatol 32(9):1751\u20131754","journal-title":"J Rheumatol"},{"issue":"10","key":"2729_CR17","first-page":"2078","volume":"34","author":"M Luc","year":"2007","unstructured":"Luc M, Gossec L, Ruyssen-Witrand A, Salliot C, Duclos M, Guignard S et al (2007) C-reactive protein predicts tumor necrosis factor-alpha blocker retention rate in axial ankylosing spondylitis. J Rheumatol 34(10):2078\u20132081","journal-title":"J Rheumatol"},{"issue":"11","key":"2729_CR18","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.24838","volume":"61","author":"MK Vries de","year":"2009","unstructured":"de Vries MK, van Eijk IC, van der Horst-Bruinsma IE, Peters MJ, Nurmohamed MT, Dijkmans BA et al (2009) Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis. Arthritis Rheum 61(11):1484\u20131490","journal-title":"Arthritis Rheum"},{"issue":"11","key":"2729_CR19","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1136\/ard.2009.124446","volume":"69","author":"B Glintborg","year":"2010","unstructured":"Glintborg B, Ostergaard M, Krogh NS, Dreyer L, Kristensen HL, Hetland ML (2010) Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8\u00a0years\u2019 surveillance in the Danish nationwide DANBIO registry. Ann Rheum Dis 69(11):2002\u20132008","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2729-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2729-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2729-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:36Z","timestamp":1559120256000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2729-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,1]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2729"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2729-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,1]]}}}